The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $132. It reported earnings in this window, a natural checkpoint for the thesis.
Dollar General
DG · a US exchange · USD · Market cap $27.5B · 194,000 employees
Dollar General Corporation, a discount retailer, provides various merchandise products in the southern, southwestern, midwestern, and eastern United States.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 08:38 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Dollar General holds its Markup at $124.57. The statistical read favours the sellers, held for 17 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 17 days |
| Price at the screen | $124.57 |
| Valuation | 16.18 trailing · 15.10 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.24 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 50.76% | Below 33% | Interest-bearing debt is 50.8% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 3.73% | Below 49% | Money owed to the company is 3.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $122.61 fair value estimate, weak competitive moat, 5.20% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. The price runs 1.6% above the base estimate.
Third-party analyst targets: 29 covering, consensus Buy. The average target sits +11% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBargain hunters meet a debt trap
Walk into any Dollar General and the shelves tell a simple story. Everyday items move in volume yet the business behind them carries too much debt to pass a basic ethical screen. We pass for that reason alone.
Revenue edges forward at just 3 percent while margins sit at 4 percent. Return on equity looks respectable at 19 percent but a weak moat and forward earnings multiple of 15.7 times leave little room for error when the fair value sits only a few dollars above the current price.
The real concern is leverage. High debt loads amplify any slowdown in footfall or rise in costs, and the market already prices the shares near analyst targets. Analysis, not advice.
| Forward P/E | 15.1xexpensive even after accounting for its growth |
| Trailing P/E | 16.2xreasonably valued |
| EPS, trailing | 7.70 |
| EPS, forward | 8.25 |
| Revenue growth | +5.2%slow but positive growth |
| Profit margin | 3.9%barely profitable |
| Return on equity | 19.7%a solid return on shareholder capital |
| FCF yield | 6.32% |
| Dividend yield | 208.00% |
| Debt to equity | 1.70a meaningful debt load worth watching |
| Current ratio | 1.21adequate liquidity, worth monitoring |
| Beta | 0.24barely tracks the market's swings |
| Short interest, float | 0.03% |
| 52-week range | 95.11 - 158.23 |
| Moat | WEAK |
| Market cap | $27.5B |
| Employees | 194,000 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDG trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $132. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $132. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (28 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (28 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (28 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (28 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (28 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 21.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (28 analysts) rates it buy, with a mean price target of $142.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (28 analysts) rates it buy, with a mean price target of $142.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Five Below Jumps 41% in a Year: Should You Still Buy the Stock? Zacks · 17 Jul 2026
- Walmart Commands a 36.74X Forward P/E: Is the Stock Worth Buying? Zacks · 16 Jul 2026
- Is Costco Stock Still a Buy After Its June Sales Update? Zacks · 16 Jul 2026
- Dollar General copies Costco with inflation-proof deal TheStreet · 16 Jul 2026
- Dollar General (DG) Stock Drops Despite Market Gains: Important Facts to Note Zacks · 14 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-26 | ELLIOTT ANITA C | Officer | 3,523 | · | |
| 2026-03-26 | VASOS TODD JOSEPH | Chief Executive Officer | 40,260 | · | |
| 2026-03-26 | TAYLOR RHONDA M | General Counsel | 6,710 | · | |
| 2026-03-26 | TAYLOR EMILY C | Chief Operating Officer | 12,581 | · | |
| 2026-03-26 | WEST RODERICK J | Officer | 8,388 | · | |
| 2026-03-26 | HERRMANN TRACEY N | Officer | 6,710 | · | |
| 2026-03-26 | LAU DONNY H. | Chief Financial Officer | 10,065 | · | |
| 2026-03-26 | WHEELER BRYAN D | Officer | 5,704 | · | |
| 2026-03-26 | WENKOFF CARMAN R | Chief Technology Officer | 6,710 | · | |
| 2026-03-26 | REARDON KATHLEEN A | Officer | 6,710 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 7 May2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 30 Mar2026 | Alan Armstrong | Republican | buy | 1K–15K |
| 24 Aug2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 21 Jul2026 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-05-05 | Brian Babin | Republican | Sale | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $104.63 | +4.3% | · | $1,043 | +4.3% |
| 2 months | $115.73 | -5.7% | · | $943 | -5.7% |
| 3 months | $135.31 | -19.3% | $0.59 | $811 | -18.9% |
| 6 months | $131.49 | -17.0% | $1.18 | $839 | -16.1% |
| 1 year | $109.03 | +0.1% | $2.36 | $1,023 | +2.3% |
| 2 years | $121.96 | -10.5% | $4.72 | $934 | -6.6% |
| 3 years | $143.70 | -24.0% | $7.08 | $809 | -19.1% |
| 5 years | $193.08 | -43.5% | $11.13 | $623 | -37.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DG does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.